HIGHLIGHTS
- who: Percutaneous Coronary Interventions and collaborators from the nd Department of Nephrology and Hypertension with Dialysis Unit, Medical University, MSklodowskiej-Curie, a, Bialystok, Poland have published the research work: Midkine: A Novel and Early Biomarker of Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions, in the Journal: (JOURNAL) of 25/04/2014
- how: Taking all these data into consideration the authors designed a prospective trial to test the hypothesis whether midkine could represent an early biomarker of contrast nephropathy in patients with normal serum creatinine. Clinical and biochemical characteristics of the population . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.